NCT03819166

Brief Summary

Application of deep touch pressure (DTP) has been suggested to provide positive effects on anxiety modulation. However, empirical and theoretical evidence linked to the clinical effects of DTP is relatively rare in the behavioral and physiological aspects. The aim of this intervention trial study designs to investigate the effect of DTP in dental treatment by quantitative analysis of behavioral assessments and physiological measurements, including the electrodermal activity and heart rate variability, were conducted to understand the modulation of the autonomic nervous system (ANS), the orchestration of sympathetic (SNS) and parasympathetic (PsNS) nervous systems.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 11, 2011

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 18, 2013

Completed
5.5 years until next milestone

First Submitted

Initial submission to the registry

January 14, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 28, 2019

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2022

Completed
Last Updated

January 15, 2021

Status Verified

January 1, 2021

Enrollment Period

2.4 years

First QC Date

January 14, 2019

Last Update Submit

January 13, 2021

Conditions

Outcome Measures

Primary Outcomes (6)

  • Heart Rate Variability (HRV)

    A non-invasive technique to investigate the effect of mental stress of the autonomic nervous system control on heart rate.

    The baseline phase is defined as the five minutes before the dental treatment. The HRV data recorded in this phase will be considered as the baseline data of this study.

  • Electrodermal Activity (EDA)

    A non-invasive technique to investigate the effect of mental stress of the sympathetic nervous system control on sweat gland of skin.

    The baseline phase is defined as the five minutes before the dental treatment. The EAD data recorded in this phase will be considered as the baseline data of this study

  • Heart Rate Variability (HRV)

    A non-invasive technique to investigate the effect of mental stress of the autonomic nervous system control on heart rate.

    The treatment phase is the period of the entire procedures of dental treatment, approximate 40-90 minutes. The HRV data will be recorded to investigate the changes both during the dental treatment and in the application of deep touch pressure.

  • Electrodermal Activity (EDA)

    A non-invasive technique to investigate the effect of mental stress of the sympathetic nervous system control on sweat gland of skin.

    The treatment phase is the period of the entire procedures of dental treatment, approximate 40-90 minutes. The EDA data will be recorded to investigate the changes both during the dental treatment and in the application of deep touch pressure.

  • Heart Rate Variability (HRV)

    A non-invasive technique to investigate the effect of mental stress of the autonomic nervous system control on heart rate.

    The post-treatment phase is defined as the five minutes after the dental treatment. The HRV data recorded in this phase will be considered as the post-treatment data which used to compare to the baseline and treatment data.

  • Electrodermal Activity (EDA)

    A non-invasive technique to investigate the effect of mental stress of the sympathetic nervous system control on sweat gland of skin.

    The post-treatment phase is defined as the five minutes after the dental treatment. The EDA data recorded in this phase will be considered as the post-treatment data which used to compare to the baseline and treatment data.

Secondary Outcomes (4)

  • Dental Anxiety Scale (DAS)

    This questionnaire will be applied in the baseline phase (immediately after HRV measurement and about 5 minutes before dental procedures) to know anxiety condition of participants before the dental treatment.

  • Dental Anxiety Scale (DAS)

    The averaged time of dental treatment is about 40-90 minutes.This questionnaire will be applied immediately after the dental treatment completion.

  • Numeric State Anxiety Scale (NSAS)

    This scale will be scored in the baseline phase (immediately after HRV measurement and about 5 minutes before dental procedures) to identify the anxiety state of participants before the dental treatment.

  • Numeric State Anxiety Scale (NSAS)

    The averaged time of dental treatment is about 40-90 minutes.This scale will be scored immediately after the dental treatment completion.

Study Arms (2)

experimental group

EXPERIMENTAL

The participants recruited in the group will receive the input of deep touch pressure during their procedures of dental treatment.

Device: with deep touch pressure application

control group

SHAM COMPARATOR

The participants recruited in the group will not receive the input of deep touch pressure during their procedures of dental treatment.

Device: without deep touch pressure application

Interventions

The deep touch pressure is applied by the weight loading devices, including but not limited to, weight blanket and weight vest.

experimental group

The deep touch pressure will not be applied.

control group

Eligibility Criteria

Age10 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who requiring tooth extraction were potentially selected to recruit.

You may not qualify if:

  • with a history of systemic diseases that would contraindicate surgical treatment
  • pregnant and lactating
  • smoking of more than 10 cigarettes per day
  • poor overnight sleep quality
  • refusal to sign the inform consent agreement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

RECRUITING

MeSH Terms

Conditions

Stomatognathic Diseases

Study Officials

  • Hsiagn Yang, DDS

    Department of Dentistry, National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hsin-Ming Chen, DDS, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2019

First Posted

January 28, 2019

Study Start

March 11, 2011

Primary Completion

July 18, 2013

Study Completion

January 30, 2022

Last Updated

January 15, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

There is not a plan to make IPD available.

Locations